Since all three factors control distinct but overlapping transcription programs and since the output of the β-catenin pathway is highly mutant-dependent, might it be possible that additional subtleties in tumor appearance and behavior are mediated through equally subtle differences in the nature of the defects affecting Hippo and NFE2L2 signaling? The gene discussed is NFE2L2; the disease is neoplasm.